Position in GRFS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$398,056
-$19,898 QoQ
Shares Held
49,633
+11.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $1,375,333,185 across 16 Drug Manufacturers - General names. GRFS ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
345,970 | $318,212,826 | |
| 2 | JNJ |
Johnson & Johnson
|
1,034,600 | $252,897,624 | |
| 3 | ABBV |
AbbVie Inc.
|
965,429 | $209,971,153 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,193,872 | $143,610,862 | |
| 5 | AMGN |
Amgen Inc
|
345,260 | $121,479,731 | |
| 6 | PFE |
Pfizer Inc
|
3,213,627 | $90,238,646 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
404,797 | $56,416,557 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
822,948 | $49,911,796 |
All Filings in GRFS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $398,056 | 49,633 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $417,954 | 44,701 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $791,222 | 79,440 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $322,954 | 35,725 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $250,655 | 35,254 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $225,833 | 30,354 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $267,083 | 30,077 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $188,605 | 29,890 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $165,977 | 24,847 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $200,057 | 17,306 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $152,656 | 16,702 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $153,814 | 16,792 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $123,528 | 16,761 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $142,944 | 16,817 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $105,366 | 17,105 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $173,685 | 14,620 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $164,746 | 14,105 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||